Inventiva S.A. (IVA)
NASDAQ: IVA
· Real-Time Price · USD
6.05
0.04 (0.67%)
At close: Sep 26, 2025, 3:59 PM
6.11
0.99%
After-hours: Sep 26, 2025, 07:00 PM EDT
0.67% (1D)
| Bid | 5.5 |
| Market Cap | 361.31M |
| Revenue (ttm) | 9.2M |
| Net Income (ttm) | -184.21M |
| EPS (ttm) | -3.64 |
| PE Ratio (ttm) | -1.66 |
| Forward PE | -5.12 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 6.11 |
| Volume | 26,915 |
| Avg. Volume (20D) | 48,167.2 |
| Open | 5.84 |
| Previous Close | 6.01 |
| Day's Range | 5.77 - 6.12 |
| 52-Week Range | 1.60 - 6.50 |
| Beta | 0.74 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for IVA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsInventiva S.A. is scheduled to release its earnings on
Sep 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+13.94%
Inventiva shares are trading higher after Piper Sa...
Unlock content with
Pro Subscription
2 months ago
+0%
Inventiva shares are trading higher after the company published Phase 2b data from its NATIVE trial in the Journal of Hepatology.
